Cite
HARVARD Citation
Musunuru, H. et al. (2021). Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life. Radiotherapy and oncology. pp. 40-46. [Online].